Deutsche Bank downgraded argenx (NASDAQ:ARGX) to Sell from Hold on Friday, citing a "clearly unfavorable" valuation setup despite the Dutch biotech's promising preliminary net sales results for Q4 ...

In a recent update, RBC Capital analysts have maintained their Outperform rating on Boston Scientific (NYSE:BSX) shares, with ...